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Abstract
Human respiratory syncytial virus (RSV) is an important cause of severe lower respiratory tract infections in infants and the
elderly. In the vast majority of cases, however, RSV infections run mild and symptoms resemble those of a common cold.
The immunological, clinical, and epidemiological profile of severe RSV infections suggests a disease caused by a virus with
typical seasonal transmission behavior, lacking clear-cut virulence factors, but instead causing disease by modifying the
host’s immune response in a way that stimulates pathogenesis. Yet, the interplay between RSV-evoked immune responses
and epidemic behavior, and how this affects the genomic evolutionary dynamics of the virus, remains poorly understood.
Here, we present a comprehensive collection of 33 novel RSV subgroup A genomes from strains sampled over the last
decade, and provide the first measurement of RSV-A genomic diversity through time in a phylodynamic framework. In
addition, we map amino acid substitutions per protein to determine mutational hotspots in specific domains. Using
Bayesian genealogical inference, we estimated the genomic evolutionary rate to be 6.4761024 (credible interval:
5.5661024, 7.3861024) substitutions/site/year, considerably slower than previous estimates based on G gene sequences
only. The G gene is however marked by elevated substitution rates compared to other RSV genes, which can be attributed
to relaxed selective constraints. In line with this, site-specific selection analyses identify the G gene as the major target of
diversifying selection. Importantly, statistical analysis demonstrates that the immune driven positive selection does not
leave a measurable imprint on the genome phylogeny, implying that RSV lineage replacement mainly follows nonselective
epidemiological processes. The roughly 50 years of RSV-A genomic evolution are characterized by a constant population
size through time and general co-circulation of lineages over many epidemic seasons – a conclusion that might be taken
into account when developing future therapeutic and preventive strategies.
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Introduction
Human respiratory syncytial virus (RSV) is the single most
important cause of severe lower respiratory tract infections (LRTI)
in infants and young children. As a consequence, RSV infections
are the most frequent cause of hospitalization of infants and young
children in industrialized countries. For example, RSV is
responsible for at least 100,000 infant hospitalizations for
pneumonia or bronchiolitis every year in the USA alone [1].
The RSV disease spectrum ranges from mild symptoms such as
rhinitis and otitis media, to severe illness such as bronchiolitis or
pneumonia, which require supportive care such as mechanical
ventilation [2]. By the age of two, most children have been infected
with RSV, with about half having experienced two or more
infections [3]. Elderly people, patients suffering from cardiopul-
monary diseases and immuno-compromised individuals also are at
risk for severe RSV disease [4,5,6]. RSV attack rates in nursing
homes in the USA are approximately 5–10% per year with a 2–
8% case fatality rate, amounting to 10,000 deaths per year among
persons above 64 years of age [4]. Among elderly persons followed
for 3 consecutive winters, RSV infection accounted for 10.6% of
hospitalizations for pneumonia, 11.4% of hospitalizations for
obstructive pulmonary disease, 5.4% for congestive heart failure,
and 7.2% for asthma [7].
RSV is classified in the genus Pneumovirus belonging to the
Paramyxoviridae family and has an enveloped, non-segmented,
single-stranded, negative sense RNA genome of approximately
15,000 nucleotides. The virus has 11 genes coding for non-
structural proteins 1 and 2 (NS1 and -2), the nucleocapsid protein
(N), phosphoprotein (P), matrix protein (M), small hydrophobic
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protein (SH), attachment glycoprotein (G), fusion glycoprotein (F),
transcription regulatory proteins M2-1 and M2-2 and, finally, a
large polymerase (L).
In Europe and North America, RSV disease occurs as well-
defined seasonal epidemic outbreaks during the winter and spring
months. On the other hand, studies in tropical countries have
often reported an increase in RSV during the rainy season, but this
has not been a consistent finding [8]. The exact factors responsible
for the typical RSV transmission dynamics are not well
understood. Multiple genotypes can be present in a single
population while new genotypes may replace older predominating
genotypes over successive epidemic seasons. Among different
populations, variation in herd immunity has been suggested to
play a role in the observed genotypic distribution patterns
[9,10,11]. Community-specific cultural and behavioral patterns
might also affect the acquisition and spread of RSV infection.
Antibody cross-reactivity patterns have led to the identification
of two antigenic subgroups (A and B) for RSV and these subgroups
have been further classified into genotypes based on genetic
divergence within the G gene [12,13,14]. Subgroup A generally
dominates during epidemics and subgroup B is mostly involved in
re-infection, although both can co-circulate [15,16,17]. Re-
infections with RSV occur frequently throughout life and it has
been suggested that the evasion of pre-existing host immune
responses is particularly facilitated by antigenic variability of the G
protein both between and within the two major antigenic
subgroups [18,19].
Development of vaccines to prevent RSV infection has been
complicated by several factors, including the risk of potentiating
naturally occurring disease. Early attempts at vaccinating children
in the 1960s with a formalin-inactivated RSV vaccine showed that
vaccinated children suffered from more severe disease on
subsequent exposure to the virus as compared to the control-
vaccinated group [20,21,22,23]. The enhanced severity of disease
has been reproduced in animal models and is thought to result
from inadequate levels of serum-neutralizing antibodies, antibody-
mediated CD4(+) memory T cell response enhancement, and
infection mediated CD8(+) memory T cell suppression
[24,25,26,27]. Live, attenuated RSV vaccines have apparently
not exacerbated pulmonary disease upon natural infection, but
have also failed to provide any appreciable degree of protection
[28,29,30]. On the basis of these and other observations, it has
been hypothesized that the development of disease in RSV
infected individuals is principally caused by immune responses
induced by the virus [31,32].
From the clinical, immunological and epidemiological profile of
RSV a picture emerges of a severe disease that is caused by a virus
with typical seasonal transmission behavior, no clear-cut virulence
factors, and the capacity to modify host immune responses in a
way that affects pathogenesis (e.g. through interfering with Toll-
like receptor-signaling [33]). However, despite its potentially
important impact on global patterns of RSV genetic diversity,
the interplay between RSV induced immune responses and the
epidemiological and evolutionary dynamics of RSV remain poorly
understood.
Phylodynamic analyses of viral genetic data are increasingly
being used to illuminate how evolutionary and ecological processes
can jointly drive fluctuations in the genetic diversity of viral
populations [34]. Such analyses hold the potential to reveal viral
population dynamics based on phylogenetic patterns, to determine
the likely short- and long-term evolutionary impacts of mutations
that enable viruses to escape host immune responses, and to
describe how these factors might collectively influence the
epidemic behavior of viruses. Although the molecular epidemiol-
ogy and evolutionary dynamics of RSV have been actively studied
in the past, much of our current knowledge in this area has been
determined through the analysis of single genes. Little is known on
how the evolutionary patterns of these individual genes – and in
particular the most actively studied G gene – reflect the genomic
dynamics of RSV. Complete genome sequences are only starting
to be generated for isolates of this species [35,36], but such efforts
may become more common with the widespread use of next
generation sequencing technologies. As recently pointed out for
viruses in general [37], generating RSV genomes is only the first
step on the path to understanding the processes that shape the
epidemiology and evolution of this virus. Here, we present
analyses of the most comprehensive collection of RSV-A complete
genomes to date, including thirty three strains sampled over the
last decade, and provide the first measurements made within a
phylodynamic framework of RSV-A genomic diversity through
time. In addition to detailed analyses of genome-wide variability
we present estimates of key evolutionary parameters such as the
genomic rate of evolution. In particular we demonstrate that
relative to the remainder of the RSV genome, the G gene has a
larger number of sites evolving under diversifying selection and is,
probably as a consequence of this, the fastest evolving RSV-A
gene. Finally, we test the degrees to which host immune responses
have impacted both patterns of selection detectable within RSV
genomes and global-scale RSV population dynamics.
Materials and Methods
Ethics Statement
This study was performed according to the guidelines of the
institutional ethics committees (METC for Dutch samples; CME
for Belgian samples) and in concordance with Dutch privacy
legislation. All anonymized clinical strains originated from the
routine diagnostic process prior to the current study. The
institutional review board (IRB) confirmed (protocol 12/320) that
viral strains are not regarded as patient-owned material and
consequently the use of these strains is not restricted in the
applicable Dutch law (‘‘Law Medical Scientific Research with
People’’, WMO; art. 1b).
Viral Isolates
Nasopharyngeal swabs and tracheal aspirates were collected
between 2001 and 2011 from children ranging in age from 2
weeks to 5 years, who were hospitalized with respiratory distress
symptoms on the pediatric wards of the Wilhelmina Children’s
Hospital in Utrecht, The Netherlands or the Gasthuisberg
University Hospital of Leuven, Belgium (Table S1). Collected
samples were cultured immediately and checked for the formation
of syncytia in HEp2 cell cultures, a typical RSV infection
phenotype. Those exhibiting RSV specific cytopathological effects
(CPE) and testing positive for RSV by real-time PCR, were
harvested and stored at 280uC.
Viral RNA Extraction, cDNA Synthesis and Real-time
Taqman PCR
RSV strains were routinely cultured on HEp2 cells for 2
passages at 33uC. Virus was harvested from cultures that exhibited
CPE in 80% of cells and viral genomic RNA was isolated using a
MagnaPure LC total nucleic acid kit (Roche Diagnostics,
Mannheim, Germany). The isolated viral RNA was reverse
transcribed using a MultiScribe reverse transcriptase kit and
random hexamers (Applied Biosystems, Foster City, CA), accord-
ing to the manufacturer’s guidelines. Primers and probes designed
on the basis of highly conserved genomic regions of the N gene for
Evolutionary Dynamics of Human RSV-A Genomes
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both RSV subgroup A (RSV-A) and B (RSV-B) were used for











Murine encephalomyocarditis virus was used as an internal
control. Samples were assayed in a 25 ml reaction mixture
containing 10 ml of cDNA, TaqMan universal PCR master mix
(Applied Biosystems, ABI), primers (900 nM RSV-A primers and
300 nM RSV-B primers), and fluorogenic probes (58.3 nM RSV-
A probe and 66.7 nM RSV-B probe) labeled with the 59 reporter
dye 6-carboxy-fluorescein (FAM) and the 39 quencher dye 6-
carboxy-tetramethyl-rhodamine (TAMRA). Amplification and
detection were performed with an ABI 7900 HT system for
2 min at 50uC, 10 min at 95uC, and 45 cycles of 15 sec at 95uC
and 1 min at 60uC. Samples were controlled for the presence of
possible inhibitors of the amplification reaction by the indicated
internal control, signals of which had to range within a clear-cut
interval.
Genomic RSV cDNA Synthesis and Sequencing
For sequencing purposes, human RSV PCR fragments were
obtained by fractional amplification of MagNAPure LC genomic
RNA isolates using the Superscript III one-step RT-PCR System
with Platinum Taq High Fidelity kit (Invitrogen) and a 9800 Fast
thermal cycler (ABI) according to the manufacturers protocol.
PCR products were applied to a 1% agarose gel and purified from
the gel by Qiaquick spin columns (Qiagen). Isolated fragments
were used for whole genome sequencing.
The majority of the listed RSV strains (Table S1) was sequenced
according to the whole genome sequence protocol recently
described by Kumaria et al [35] using the conventional Sanger
technique. Fragments ranging between 650 and 1,400 nucleotides
were sequenced on an ABI 3730 48-capillary DNA analyzer using
Big-Dye Terminator 3.1 (ABI). Table S2 provides an overview of
the primers used. Indicated strains (Table S1) were (partly)
sequenced via commercial 454-sequencing (Keygene, Wagenin-
gen, The Netherlands). The resulting sequence information was
assembled into RSV whole genome sequences through alignment
with the reference RSV A2 strain (M74568) using Seqman
software (DNASTAR lasergene 8).
Protein Substitution Analysis
Gene sequences were extracted from the whole genome
sequences and the consensus of each gene was derived from the
set of patient and reference strains using Seqman software. Gene
sequences were translated into protein coding sequences using
Seaview4 and subsequently aligned via the EMBL-EBI Clus-
talW2-Multiple Sequence Alignment tool. For each strain,
sequence variability scores were calculated per gene relative to
the consensus sequence for all clinical and reference strains.
Protein substitutions per site were mapped using the program
Plot0.997. For the RSV fusion protein, substitutions were marked
in the 3RKI_PDG crystal structure with MacPyMOL (available at
http://www.pymol.org/pymol). The NetNGlyc 1.0 server [38]
was used to predict the gain and loss of N-glycosylation sites.
Data Set Compilation and Recombination Analysis
To study the complete genome evolutionary dynamics of RSV,
we combined our newly obtained complete genomes with the
genomes from the recent studies of Kumaria et al. (2011) and
Rebuffo-Scheer et al. (2011). The latter (JF920046-JF920070),
were recovered from nasopharyngeal and nasal swabs collected
from patients in the Milwaukee metro area. A total of 72 RSV-A
complete genomes were aligned using Mafft [39] and manually
edited in Se-Al (available at http://tree.bio.ed.ac.uk/software/
seal/). Recombination was analyzed using the RDP, GENE-
CONV, RECSCAN, MAXCHI, CHIMAERA, SISCAN, and
3SEQ recombination detection methods implemented in RDP3
[40,41]. Only potential recombination events detected by two or
more of these methods, together with phylogenetic evidence of
recombination, were considered robust evidence of likely recom-
bination. Based on the considerable recombination signal detected
in the complete genomes obtained by Kumaria et al. (2011),
further analyses were performed without these 14 sequences (on an
alignment of 58 sequences). Since six recombination events evident
within five of the remaining sequences may potentially undermine
the validity of any phylogeny based analysis (the evolutionary
history of recombinant sequences can in many cases not be
adequately described by a single phylogenetic tree), we took the
necessary steps to appropriately account for these recombination
events. We noted that the five recombinant genomes all had a
clear majority of their sequences inherited from a single major
parent and a minority of sequences inherited from one or more
minor parents (Fig. S1). We pursued two strategies to account for
these recombination events. In the first strategy we simply
discarded the portion of recombinant sequences that had been
inherited from their minor parents (corresponding to the B and C
regions in Figure S1) and replaced these ‘‘deleted’’ genomic sites in
the five aligned recombinant sequences with gap characters (i.e. we
treated these sites as though they are unobserved in the
probabilistic inferences). In the second strategy rather than simply
deleting the genomic sites apparently derived from the minor
parent, we separated the genomic regions of the recombinants
derived from their major and minor parents and treated these
separated regions as though they were separately sampled
sequences. Importantly, a single phylogenetic history could be
safely assumed for the genomic sequence datasets yielded by both
strategies. For the selection pressure analyses of the complete
genome, we stripped the non-coding regions from the alignments
and extracted a concatenated coding gene alignment. To
scrutinize the evolutionary dynamics of the G gene, we also
aligned the G gene sequences of our complete genomes to a data
set previously analyzed by Zlateva et al. (2004; Table S3), resulting
in an alignment of 185 sequences encompassing amino acid
position 91 to 297 of the G protein.
Bayesian Estimation of RSV Evolutionary History
To evaluate whether our complete genome data set showed a
clear signal of nucleotide divergence throughout the sampling time
interval, we explored linear regressions of root-to-tip divergence as
a function of sampling time using Path-O-Gen (available at
http://tree.bio.ed.ac.uk/software/pathogen/) [42]. For this pur-
pose, we employed maximum likelihood trees reconstructed using
PhyML [43] based on a general time-reversible (GTR) substitution
model and a discretized gamma distribution to model rate
variation among sites. The exact sampling data was known for
all genomes except for six sequences obtained from Rebuffo-
Scheer et al. (2011), which were set at the midpoint of the reported
sampling year for this exploratory analysis.
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We reconstructed the RSV evolutionary and demographic
history using Bayesian Markov chain Monte Carlo (MCMC) in
BEAST v1.7 [44]. BEAST infers a posterior distribution of time-
measured genealogies based on a full probabilistic model including
a molecular clock model, a nucleotide substitution model and a
coalescent model as prior distribution for the tree. We used a
general time-reversible (GTR) substitution model and a discretized
gamma distribution to model rate variation among sites. To
examine substitution rate variability across the genome, we also
applied a partition model that allowed for separate substitution
rates for the different genes and the single non-coding genome
region. The fit of strict and relaxed clock models, assuming
homogenous and heterogeneous substitution rates across the
branches of the phylogeny respectively [45], was assessed based
on a range of statistics including marginal likelihoods estimated
using the harmonic mean, Akaike’s information criterion through
MCMC (AICM), path sampling (PS) estimators and stepping-
stone sampling (SS) estimators [46,47]. For the six sequences for
which the exact sampling date was not available, we estimated the
tip ages constraining them within a time interval of one year (using
a uniform prior, [48]). We used the Bayesian skyline plot model as
a flexible demographic prior allowing us to reconstruct how the
effective population size changed through time [49]. MCMC
analyses were run until convergence could be safely assumed, as
evaluated using Tracer (available at http://tree.bio.ed.ac.uk/
software/tracer/). Marginal posterior distributions for the evolu-
tionary rate and divergence times, such as the times to most recent
common ancestors (TMRCA) of various groups of sequences, were
summarized using means and 95% highest posterior density
intervals (HPDs). We represented the posterior tree distribution
using a maximum clade credibility (MCC) tree annotated with
divergence time and evolutionary rate summaries and provided a
visualization of this tree using FigTree (http://tree.bio.ed.ac.uk/
software/figtree/) [45].
To test whether the phylogenetic tree shape in the posterior
distribution deviated from neutral expectations, we performed a
genealogical test based on posterior predictive simulation [50].
Briefly, we summarize the tree shapes obtained by our Bayesian
coalescent analysis using the genealogical Fu and Li statistic (DF).
This statistic compares the length of terminal branches to the total
length of the coalescent genealogy and returns negative values for
long terminal branch lengths, which in turn indicates an excess of
slightly deleterious mutations on these branches and hence a
deviation from neutrality. The posterior predictive simulation
randomly simulates trees with the same number of tips, the same
tip ages, and under the same neutral coalescent model as the one
applied to the real data. We employed the posterior predictive
simulation extension that allows simulation of trees under the
Bayesian skyline plot model [51]. Finally, we derive P-values for
this genealogical neutrality test based on the frequency at which
the DF of the inferred trees was more extreme than the DF of the
simulated trees.
Selective Pressure Analyses
For the concatenated coding genes, we identified sites under
diversifying selection using a fixed-effects likelihood (FEL)
approach [52] and a recently developed renaissance counting
(RC) procedure [53]. The FEL method fits codon models to each
site independently and performs a likelihood ratio test to evaluate
whether a model that assumes equal non-synonymous and
synonymous rates (dN = dS) can be rejected in favor of a model
that allows for different dN and dS rates. The RC approach
combines stochastic mapping under nucleotide substitution models
and empirical Bayes to estimate site-specific dN/dS ratios, and
quantifies their uncertainty while accommodating phylogenetic
uncertainty. Sites yielding 95% dN/dS credible intervals (CI) that
do not include 1 reject neutrality and were considered to be
evolving under positive selection. Following the advice of
Kosakovsky Pond et al. (2005), we considered a consensus
approach to identify sites evolving under positive diversifying
selection. We only listed sites for which the FEL approach
produces P-values ,0.1 and for which the lower 95% CI for the
RC estimate is larger than 1.
To detect diversifying positive selection in the G gene data set,
we also used a random-effects likelihood (REL) [54] approach in
addition to FEL and RC. This method fits a codon model to the
entire alignment but allows the dN/dS ratio to vary among sites.
Positively selected sites were then identified using an empirical
Bayes approach. We first tested the fit of three codon models of
different complexity: a model that allows for different dN rates
among sites but keeps the dS rate constant among sites (‘Non-
synonymous’), a model that allows both dN and dS to vary among
sites (‘Dual’), and, finally, a variant of the Dual model that also
allows dN to vary among branches in the phylogeny (‘Lineage
Dual’). We used a general discrete distribution with three
categories of sites to model dN and dS variation among sites in
these substitution models. We applied the empirical Bayes method
to identify positively selected sites to the best fitting codon model
according to the AICM and used a log Bayes Factor larger than
three as a cut-off. We only listed sites that met the cut-offs for at
least two methods applied to the G gene data set and, in the results
section below, listed in bold those that met the criteria for all three
methods (FEL P-value ,0.1, RC 95% lower CI value .1, REL ln
BF .3).
Finally, we also investigated both pervasive an episodic
diversifying selection using a recently developed mixed-effects
model of evolution (MEME) [55]. MEME relaxes the assumption
that the strength and direction of natural selection is constant
across all lineages by allowing the distribution of dN/dS to vary
from site to site and also from branch to a branch at a site. As an
extension of FEL, MEME fits a codon model with two categories
of lineage-specific dN rates to each site, one that is # dS (referred to
as b2) and one that is unrestricted (b+), and tests this against a
model where the unrestricted dN is also # dS using a likelihood
ratio test. We report positively selected sites with a P-value #0.05,
which controls the rate of false positives fairly well [55], and
include the estimate of b+ and the proportion of branches
estimated to be part of this dN rate class (p
+).
Nucleotide Sequence Accession Numbers
The nucleotide sequences from the Dutch and Belgian RSV
isolates were submitted to GenBank under the accession numbers
JQ901447-JQ901458, JX015479-JX015499. Prototype reference
strains A2 (M74568.1), Long (AY911262.1), Line19 (FJ614813.1)
and RSS-2 (NC_001803.1) were included in protein analysis
studies.
Results
Human RSV-A Protein Substitution Mapping
Protein sequences of thirty-three Dutch-Belgian clinical strains
(Table S1) and four reference lab-strains were aligned and
compared to the RSV consensus. Changes in amino acid residues
from all strains were mapped for each RSV protein to determine
the protein substitution density for all proteins (Fig. 1). The
percentage of sequence variability indicates the degree of variation
from the consensus for each strain (Fig. 1 and Table S4). G and
M2-2 are the most variable proteins with 10–18% and 9–20%
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variability, respectively. The relatively high protein sequence
variation observed for RSV G suggests more relaxed selective
constraints in this protein and could even indicate, as has been
previously identified [56], instances of molecular adaptation. The
ectodomain mucin-like regions of RSV G are two highly variable
regions that are separated by a central conserved region
containing the heparin-binding domain (HBD) (Fig. 2). The
majority of non-conserved substitutions are located in these two
regions. The C-terminal part of the RSV G immunogenic domain
[57] has the highest substitution density, but non-conserved
substitutions are detected throughout this domain. The RSV G
immunogenic domain (a.a. 159–186), previously shown to be
homologous to the TNF receptor fourth subdomain [58], shows
only a few substitutions. However, the N161D substitution, as
detected in both the RSV G immunogenic domain and the TNFr
homologous domain, was present in ten out of thirty-seven strains.
Interestingly, this residue is located in the protective epitope 152–
163 of the central conserved domain of RSV G [59]. For several
RSV strains, asparagine substitutions in the G protein result in the
gain or loss of predicted N-glycosylation sites either by direct
changes in the Asn-Xaa-Ser/Thr N-glycosylation sequons or by
alterations in the surrounding sequence (Table S5).
The RSV F signal peptide that is involved in F protein
translocation to the ER [60] is a major substitution hotspot
(Fig. 3A) whereas other parts of RSV F are rather conserved. Most
substitutions in the mature F protein are located at the surface of
this fusion protein (Fig. 3B), which, therefore, might affect either
antibody binding or interactions with cellular receptors. However,
previously recognized antigenic regions [61] appear to be highly
conserved. Non-conserved substitutions in the fusion protein are
only found in the prototype strains RSV-Long (K80N, S213R) and
RSV-line19 (E66K, S213R, T357K), as well as in the clinical
strain 05-000417 (S213R). The E66K and K80N replacements are
located in the F2 domain, which is involved in direct interaction
with host cells and, accordingly, is a determinant of host species
specificity. N-glycosylation sites are predicted for amino acid
residues 27, 70, 116, 120 and 126. All of these are situated within
the F2 domain and, in contrast to the N-glycosylation sites
predicted for RSV G, are highly conserved with the exception of
reference strain RSV-A2 and clinical strain 01-002279 that did not
show N-glycosylation potential at position 120. The site at position
500 which was earlier predicted to have glycosylation potential
[62] was not identified as such here (glycosylation potential ,0.5).
Figure 1. Sequence variability in RSV proteins. The number of substitutions per site (black bars) and the sequence variability (%) in each RSV
protein calculated per strain relative to the consensus.
doi:10.1371/journal.pone.0051439.g001
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Figure 2. Amino acid substitutions in specific domains of the RSV G protein. Indicated are the transmembrane domain (TM), heparin
binding domain (HBD), N-terminal cytosolic domain, C-terminal ectodomain, the immunogenic internal domain and the region showing partial
homology with the fourth subdomain of the 55 kDa TNFr. Dashed lines represent the mucin-like regions. N-glycosylation sites are indicated by black
dots, conserved substitutions by black bars and non-conserved substitutions by red bars. Positively selected sites are marked by asterisks.
doi:10.1371/journal.pone.0051439.g002
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Figure 3. Amino acid substitutions in specific domains of the RSV F protein. A) Indicated are the signal peptide (S), fusion peptide (F),
transmembrane domain (TM), F1 and F2 domains, antigenic sites I, II and IV (black triangles), and N-glycosylation sites (black dots). B) Substitutions
marked in the 3D structure of the trimeric fusion protein. Amino acid class changes are indicated in red, orange indicating similar class.
doi:10.1371/journal.pone.0051439.g003
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Potentially Artifactual Recombination Signals within
Some RSV Genomes
An initial screen for recombination within a dataset containing
the 39 RSV sequences available from the study of Kumaria et al.
(2011) and Rebuffo-Scheer et al. (2011), together with the 33 newly
determined sequences described here, revealed evidence of
approximately 64 unique recombination events within the
evolutionary histories of these sequences. Collectively 55 of these
recombination events were clustered within the 14 RSV genome
sequences deposited by Kumaria et al. (2011). The pattern of
recombination within these sequences was extremely complex
with, for example isolate RSV-12 (accession number GU591769)
containing at least 10 recombination breakpoints and genome
regions apparently derived from at least five different parental
viruses.
The fact that signals of recombination were mostly concentrated
within a set of genomes all determined within a single research
laboratory suggested that these genomes might all be recombinant
sequence assembly or amplification artifacts. Using the permuta-
tion-based recombination breakpoint-clustering test employed in
[63], we detected an extremely significant association (p,0.0001)
between breakpoint positions and the locations of the primer
binding sites used to sequence these genomes. This very strongly
suggests that the recombination signals detectable within these
sequences are sequence assembly artifacts and we therefore
excluded these sequences from subsequent recombination analy-
ses.
Further recombination analyses indicated that five of the
Milwaukee isolates, A/WI/629-4302/98, A/WI/629-4285/98,
A/WI/629-3734/98, A/WI/629-4239/98 and A/WI/629-4111/
98 [36] were detectably recombinant (collectively containing
evidence of six recombination events; Figure S1). As the majority
of these recombinant genomes (.70% of their sequences) were
apparently derived from a single major parental virus, they were
included in subsequent analyses with, in a ‘‘removed’’ dataset, the
fragments derived from the minor parental viruses removed or, in
a ‘‘distributed’’ dataset, the fragments derived from the different
parents being separated into two different sequences.
Seven out of eleven Dutch-Belgian strains that were sequenced
via the 454-sequencing method also showed some degree of
recombination. After re-analyzing these (Table S1) strains by
conventional Sanger sequencing, recombination events were no
longer present confirming that short-read sequencing techniques
and their associated contig-assembly methods can, in many cases
produce artifactual recombinant viral genomes: A fact that should
encourage all future studies of RSV whole genome sequences to
explicitly account for recombination.
A Bayesian Reconstruction of RSV-A Complete Genome
Evolutionary History
An exploratory linear regression analysis of root-tip-divergence
as a function of sampling time indicated that there is a clear
temporal signal for nucleotide divergence in the RSV-A complete
genomes sampled over the last thirteen years (Fig. S2), justifying
the application of a dated tip molecular clock model in the
Bayesian evolutionary reconstruction. We compared a strict and
relaxed clock model using different approaches to assess model fit.
Although this did not provide consistent results (Table S6), path
sampling and stepping-stone sampling, which have recently been
shown to provide the most accurate results [47], both rejected the
assumption of a constant substitution rate across phylogenetic tree
branches and hence we used this model in further analyses. We
represent the posterior tree distribution for the ‘distributed’ RSV-
A complete genome data set using a maximum clade credibility
(MCC) tree in Figure 4. The corresponding parts of each mosaic
genome identified using RDP3 do not cluster together in this tree
(green and black arrows/stars in the figure), which confirms that
these genome regions are likely derived from genetically divergent
viruses. The smaller genomic stretches extracted from these
mosaic genomes are generally very closely related to other
Milwaukee genomes, with four of them nearly identical to one
another, highlighting the nonrandom nature of these mosaic
patterns. The MCC tree for the ‘removed’ RSV-A complete
genome data set had the same topology as for the ‘distributed’
RSV-A data set (data not shown).
The complete genome phylogeny does not indicate geograph-
ical or temporal clustering patterns because the Dutch-Belgian and
Milwaukee strains are phylogenetically interspersed and strains
from different epidemic seasons are present in the same clusters.
For further classification of our new strains, we compared the G
gene sequences extracted from the complete genomes to previ-
ously described sequences that have been assigned to specific
subgroup A genotype lineages GA1, GA2, GA4, GA5 or GA7
[36,64] (Fig. S3). The Dutch-Belgian strains predominantly belong
to the GA2 and GA5 lineages, and in this study, six Milwaukee
strains (A/WI/629-4071/98, A/WI/629-3248/98, A/WI/629-
4302/98, A/WI/629-4255/98, A/WI/629-3868/98 and A/WI/
629-4266/98), which were previously assigned to the GA7 lineage,
were classified as genotype GA2 in our analysis.
The RSV-A complete genome evolutionary history dates back
to 1964 (95% credibility interval between 1956 and 1973). The
inclusion of older strains sampled in 1954 and 1961 in the G gene
pushes the MRCA further back in time (1943 [1923,1954],
Table 1). The Bayesian skyline model indicated that RSV
populations over the past 70 years have been characterized by a
constant degree of relative genetic diversity through time (for both
the distributed and the removed data sets, Fig. S4). The genomic
evolutionary rate was estimated to be 6.4761024 substitutions per
site per year (95% credibility intervals ranging from 5.5661024 to
7.3861024), which is considerably slower than rates previously
estimated using only the G gene (1.8361023; [64]). Therefore, we
investigated evolutionary rate variability across the genome by
partitioning the various genes and the non-coding regions in our
Bayesian estimation approach (Fig. 5). This revealed elevated
substitution rates in the non-coding regions and the G gene. The
latter also has the highest sequence variability score (5–9%
variability; Fig. S5). The relatively high rate we have estimated for
the G gene partition is in good agreement with previous estimates
of substitution rates in this gene [64] and indicates relaxed
selective pressures operating on the G gene relative to other RSV
genes. Specifically, other genes were considerably more conserved
than the G gene and showed substitution rates that were 3- to 4-
fold lower than those of the G gene.
Site-specific Patterns of Selective Pressure
To identify positively selected sites in the RSV-A genome, we
used a fixed-effects likelihood (FEL) approach and a recently
developed renaissance counting (RC) method to evaluate non-
synomous/synonymous substitution rate ratios (dN/dS) at each
codon position. Table 2 lists sites that are apparently evolving
under positive selection given the consensus cut-off values we
propose for both methods (see Methods). The sites marked in bold
also meet more stringent cut-offs for one of the two methods. As
expected from the evolutionary rate variability across the genome,
the majority of positively selected sites are found in the G gene,
which can be interpreted as evidence for the action of diversifying
selection at these sites. Single positively selected sites were detected
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in the L gene (site 104), the N gene (site 216) and the M2 gene (site
117; with support for the latter two sites being lower than that for
the L gene site).
To further scrutinize the instances of diversifying selection in the
G gene, we analyzed the larger G gene data sets with the same
methods and an additional random-effects likelihood (REL)
approach. For the latter, we first tested, using an AIC-based
approach, whether the applied codon substitution model needed
to account for nonsynonymous and synonymous rate variability
across sites and/or branches (Table 3). We found strong evidence
for both nonsynonymous and synonymous rate variability across
sites, but no support for a model that also accommodates a
separate nonsynonymous rate for each branch. Sites that were
found positively selected according to the cut-offs for at least two
methods are listed in Table 2; sites that meet the criteria for all
three methods are listed in bold. There is only partial agreement
between the sites identified in the G gene data (underlined in
Table 2) and those found to be positively selected based on the G
genes sampled from the complete genome dataset. Most positively
selected sites were detected within the two hyper-variable regions
of the G protein ectodomain (marked with an * in Figure 2). The
positively selected site 242 is a predicted N-glycosylation site and
substitutions can result in loss of glycosylation.
The methods we applied to investigate site-specific selective
patterns will generally identify sites that are under positive
diversifying selection in most lineages of the tree (pervasive
Figure 4. Phylogeny based on whole genomic sequences. Distribution of Dutch-Belgian strains (blue) and Milwaukee strains (green). A color
gradient (blue = slow, black = average, red = fast) reflects the variation in evolutionary rates among branches; node bars depict the credibility intervals
for nodes showing a posterior probability support .95% (blue bar) or ,95% (yellow bar). Recombinant partitions are indicated with arrows and
asterisks.
doi:10.1371/journal.pone.0051439.g004
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diversifying selection). However, sites may also experience
diversifying selection in a restricted number of branches (episodic
diversifying selection). To discriminate between these processes,
and to identify sites under episodic diversifying selection in
particular, we applied a recently developed approach that relaxes
the assumption of constant diversifying selection throughout time
(MEME, [55]; Table 4). MEME identified 16 sites under positive
diversifying selection (P-value #0.05), six of which were already
pinpointed by the other methods (in bold in Table 4). Not
surprisingly, there is a large proportion branches estimated to be
under diversifying selection (p+) for these six sites. Most other sites
are candidates for sites under episodic diversifying selection, some
of which only implicate a small subset of branches but with high
nonsynonymous substitution rates (b+). To contrast the substitu-
tion history for sites under pervasive and episodic selection, we
mapped the amino acid residues for four G gene sites to the
internal MCC tree nodes in Figure S6. This demonstrates that the
amino acid patterns for the two sites with the highest RC dN/dS
estimates (site 274 and 290 under pervasive selection), are the
result of a relatively rich substitution history on both external an
internal branches, whereas substitutions for the two sites under
episodic selection (site 154 and 255) occur on only three external
branches and one external branch respectively. We caution against
over-interpreting the latter because a single substitution on an
external branch may also reflect a deleterious mutation that has
been weeded out by purifying selection [65].
The Neutral Phylodynamics of RSV-A
To test the impact of diversifying selection in the G gene on
virus circulation patterns, we conducted a genealogical test of
neutrality using posterior predictive simulation. Comparison of the
tree shapes inferred from the complete genomes to those obtained
by simulating under the neutral model with the same population
dynamics indicated that neutrality could not be rejected at the
population level (P = 0.24). The same holds true for the G gene
data set although the inclusion of older samples and the resulting
longer time scale may have resulted in a lower P-value in this case
(P = 0.08).
Discussion
Here we present the first study describing RSV-A whole-
genomic diversity through time using phylodynamic inference. We
mapped the rate and density of nucleotide substitutions in viral
gene products to provide an indication of the relative importance
of individual protein evolutionary dynamics in RSV replication or
immune evasion. The evolutionary and population dynamics of
RSV-A were estimated using a Bayesian coalescent approach,
based on two different datasets of sequences from time-stamped
strains collected between 2001 and 2011. One set was recently
collected in the Milwaukee area [36]. Like previous molecular
evolution studies [64,66], Rebuffo-Scheer et al [35,36] described
the epidemiology of these strains according to G gene genotyping.
The current study adds another set of thirty-three complete
genomic sequences to the literature, enabling in-depth examina-
tion of RSV evolutionary dynamics by Bayesian genealogical
inference. Although the collective sampling arose from a few
Figure 5. Evolutionary rate estimates for the different genes and for the non-coding partition. Distributed (blue square) and removed
(red triangle) data sets.
doi:10.1371/journal.pone.0051439.g005





Distributed 6.47E204 5.56E204 7.38E204
Removed 6.44E204 5.52E204 7.46E204
G gene 2.22E203 1.93E203 2.56E203
TMRCA (date) Distributed 1964 1957 1972
Removed 1964 1956 1973
G gene 1942 1929 1953
doi:10.1371/journal.pone.0051439.t001
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specific locations, the general absence of population substructure
and the co-circulation of different lineages through time ensure
that we analyzed a representative RSV-A genomic sample.
Most nucleotide sequence variability was detected in the non-
coding regions, as well as the M2-2 and G genes. The role of
intergenic non-coding regions and their high sequence variability
is unknown. In the G and M2-2 proteins high nucleotide sequence
variability is correlated with elevated amino acid substitution rates.
Variability in the M2-2 transcription regulatory protein sequences
could largely be attributed to substitutions in reference strains
(Long, Line19, and A2), suggesting that this variability may be
attributable to adaptation to artificial growth conditions during
long-term culturing. Given the role of M2-2 in switching from
transcription to RNA replication during the virus infection cycle,
together with our observation that none of the clinical strains
shows such increased variability, we hypothesize that the absence
Table 2. Site-specific positive selection pressure.
RC FEL REL
Data set Positive selected site Gene dN/dS dN-dS P value E[dN/dS] Log(BF)
Full genome 286 G 2.62 (2.06,3.95) 9.49 ,0.01 N/A N/A
244 G 2.54 (2.04,3.72) 8.12 0.1 N/A N/A
274 G 2.51 (2.05,3.69) 6.43 0.02 N/A N/A
250 G 2.11 (1.71,3.09) 5.17 0.01 N/A N/A
104 L 1.73 (1.37,2.65) 3.55 0.08 N/A N/A
101 G 1.72 (1.29,2.59) 3.67 0.04 N/A N/A
258 G 1.72 (1.38,2.51) 3.86 0.04 N/A N/A
216 N 1.32 (1.05,1.99) 4.15 0.1 N/A N/A
117 M2 1.30 (1.00,1.99) 4.31 0.1 N/A N/A
237 G 1.29 (1.05,1.89) 4 0.04 N/A N/A
G gene 274 G 4.08 (2.63,6.39) 3.11 0.01 2.73 4.3
290 G 3.19 (2.04,4.95) 1.81 0.03 2.71 4.14
244 G 2.81 (1.83,4.34) 1.99 0.11 2.48 3.26
258 G 2.52 (1.65,3.94) 1.58 0.03 2.68 3.99
146 G 2.19 (1.33,3.38) 1.31 0.04 2.47 3.18
286 G 2.00 (1.32,3.16) 1.67 0.05 2.7 4.13
285 G 1.92 (1.25,2.98) 1.05 0.08 1.65 1.37
242 G 1.91 (1.24,2.99) 1.92 0.02 2.55 3.45
255 G 1.90 (1.25,2.92) 1.72 ,0.01 2.55 3.41
132 G 1.16 (0.74,1.82) 2.12 0.03 2.71 4.15
Sites marked in bold are positive selected sites that meet the criteria of all applied methods. Underlined sites are positive selected sites that agree with the G gene and
full genome analysis. RC = Renaissance Counting, FEL = Fixed-Effect Likelihood, REL = Random-Effects Likelihood, dN = non-synonymous substitution, dS = synonymous
substitution and log(BF) = Bayes Factor logarithm. REL could not be acquired for the whole genome data set (N/A).
doi:10.1371/journal.pone.0051439.t002
Table 3. Model-fit of random-effect likelihood (REL) models.
Model Log L AIC cv(dS)
Nonsynonymous 26376.14 13506.28 0
Dual 26345.39 13452.78 7.29
Lineage Dual 26181.06 13856.12 13.18
Log L = logarithm of the maximum lilelihood value for the model.
AIC = value of the Akaike Information Criterion model selection index.
CV(dS) = coefficient of variation of the synonymous substitution distribution.
doi:10.1371/journal.pone.0051439.t003
Table 4. Sites under episodic diversifying selection in the G
gene data set.
Positive selected
site b+ p+ P value
154 2010.12 0.01 0.00
255 19.06 0.09 0.00
274 3.48 1.00 0.00
224 113.89 0.01 0.01
290 2.12 1.00 0.02
256 23.86 0.13 0.02
297 18.83 0.11 0.03
250 21.85 0.12 0.03
286 2.47 1.00 0.03
132 1.67 1.00 0.03
146 1.50 1.00 0.04
247 1.18 1.00 0.04
273 1.37 0.64 0.04
218 252.07 0.01 0.04
258 3.95 0.44 0.05
124 3.96 0.44 0.05
Sites marked in bold are positive selected sites that meet the criteria of all
applied methods.
doi:10.1371/journal.pone.0051439.t004
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of immunological constraints on the cultured isolates may have
allowed changes in this switching protein that facilitate more
efficient packaging and increased viral yields in vitro. We did not
detect any difference in the nucleotide sequence of three RSV
strains sequenced either directly from patient isolates or after
passaging on HEp2 cells for three culture rounds (data not shown).
Apparently, short-term culturing does not result in a noticeable
accumulation of culture adaptive substitutions and it may
therefore be acceptable to use whole genomic sequences from
RSV isolates with low culture passage levels in future genetic
analyses. The G protein is the virus’ most immunogenic protein
and it has been suggested that neutralizing antibodies drive
positive selection for immune escape variants of the ectodomain
[67]. All other RSV genes show high degrees of conservation,
suggesting that the impact of immune pressures on the evolution of
these genes is minimal. Nevertheless the substitutions observed in
these genes might very well affect RSV fitness and its transmission
dynamics. The exact mapping of conserved sites throughout the
genome might be very useful for both future research into the
biological functions of these regions as well as for the development
of therapeutic and preventive strategies.
An important prerequisite to performing phylogenetic inference
is a thorough check of recombination events occurring in the
genomes being analyzed. Recombination in RSV genomes is
unprecedented in natural isolates and has only very rarely been
detected under controlled laboratory conditions [68]. Therefore, it
is not very likely that any of the recombination events detected
here are the product of natural RSV evolutionary processes.
Indeed, our analyses suggest that in both the case of sequences
deposited by Kumaria et al. (2011), as well as in seven of our own
454-derived sequences, the recombinant sequences are likely to be
either PCR or sequence assembly artifacts. Especially our own
findings underscore the potential pitfalls of applying phylogenetics-
based analytical approaches to sequences derived through the
application of short-read sequencing techniques. To incorporate
published strains with recombination signal, we compared a data
set where minor recombinant parts were removed and a data set
where sequence parts with different phylogenetic clustering were
distributed over multiple taxa. These data sets yielded highly
similar evolutionary rate and demographic estimates, but we noted
that a large number of such distributed strains may complicate the
interpretation of demographic inferences. This is because the
relationship between viral coalescent rates and the change in
effective number of infections through time only holds when each
individual is represented by a single sequence.
To assess whether the genotype grouping is consistent when
different genomic regions are used, we compared the phylogenetic
trees constructed from all single genes, as well as the whole
genome based tree. The analysis of the non-recombinant complete
genome strains revealed consistent genotype clustering patterns
constructed from all single genes, including the most variable G
gene (data not shown). Therefore, we conclude that genotyping
based only on G gene sequences, appears to be a suitable method
for assigning genotypes to RSV strains. However, in general there
are no equidistant clusters corresponding to RSV genotypes and
differences in the analyzed strain population, i.e. typing strains
against different background populations, might give rise to
different classifications as observed for six Milwaukee strains (A/
WI/629-4071/98, A/WI/629-3248/98, A/WI/629-4302/98, A/
WI/629-4255/98, A/WI/629-3868/98 and A/WI/629-4266/
98), which were previously assigned to the GA7 lineage, but are
classified as genotype GA2 in our analysis. This indicates that RSV
genotyping may be intrinsically volatile.
Changes in amino acid sites that are either N-glycosylated or
susceptible to selective pressure correlate with RSV phenotypic
differences and variations in RSV infectiousness. This may
ultimately affect the outcome of RSV infection and transmission
dynamics. We studied the N-glycosylation sites within the two
major RSV glycoproteins, F and G. Here we observed differences
in the predicted N-glycosylation sites for the F protein when
comparing our data to those of Zimmer et al [62]. Modifications in
asparagine residues and the related alterations in N-glycosylation
potential could affect RSV G and F protein folding, possibly
resulting in altered virus-host attachment, changes in immune
evasion strategies or distorted fusion abilities. Zimmer et al used
the RSV-Long strain to conduct radio-immunoprecipitations with
recombinant RSV F mutants to determine the N-glycan positions.
They reported glycosylation at N27, N70 and N500. Here,
position N500, which is known to be required for efficient syncytia
formation, was not predicted to be glycosylated, underscoring the
need for in vitro confirmation of predicted N-glycosylation sites. In
addition, N-glycosylation is not only determined by sequence
composition, but also heavily depends on the type of host cells that
are infected [69].
Selective pressure analysis showed that the RSV genes have
predominantly negatively selected, or neutrally evolving sites.
Only the RSV G gene displays clear evidence of pervasive positive
diversifying selection. Using the full genome dataset we detected
positively selected sites at G protein positions 101, 237, 244, 250,
258, 274, and 286. In the larger G gene exclusive dataset,
additional positively selected sites at positions 146, 242, 255 and
258 were detected by the various detection methods (Table 2).
Positively selected site 237 has an asparagine residue with N-
glycosylation potential [18] for approximately 50% of the strains
included in this study. More positively selected sites were found at
predicted N-glycosylation positions 242, 244, 250 and 258.
Substitutions at positions 274 and 286 have previously been
associated with antibody escape [70]. Less is known about the
effects of amino acid replacements at sites 101, 146, and 255,
although positions 101 and 146 fall within the immunogenic
region of RSV G [57]. Clearly, the exact G gene sites identified as
evolving under positive selection are not consistent among
different studies [64,71]. The vast majority of previously described
sites [59,72] were not predicted here, even when using the G gene
only data set. Among the sites predicted in this study, positions
242, 255 and 258 were also predicted by Botosso et al. (2009) [71].
Differences in positively selected sites can be attributed to different
data sets and/or the use of different analytical methods. For
example, unaccounted recombination is known to yield false
evidence of positive selection. The fact that the amount of
sequence data strongly impacts the power of selection analyses is
evident from the positively selected sites in the G gene when
comparing the smaller complete genome data set to the larger G
gene specific data set. Our codon model comparison also indicates
an important degree of variation in synonymous substitution rates
among sites, which could result in sites being falsely identified as
evolving under positive diversifying selection if not accounted for.
The sensitivity to sequence sampling and the amount of data is less
of an issue for the recently developed MEME approach [55],
which also captures episodic diversifying selection by disentangling
lineages under purifying and positive selection for each site.
MEME confirmed six sites under pervasive diversifying selection,
but also identifies a considerable number of sites under episodic
diversifying selection. This confirms the notion that site-specific
positive selection may have been largely underestimated because
purifying selection in many lineages can mask episodic adaptation.
Evolutionary Dynamics of Human RSV-A Genomes
PLOS ONE | www.plosone.org 12 December 2012 | Volume 7 | Issue 12 | e51439
The degree of phylogenetic intermixing of samples from
different geographical regions in the maximum clade credibility
tree indicates that there is likely very little, if any, temporal or long-
term geographical structuring of RSV populations. Several
genotypes may co-circulate and selection leading to the replace-
ment of predominating genotypes is likely to be far more sporadic
than that which, for example, occurs with influenza viruses where
high host population-wide prevalence’s of antibodies targeting the
hemagglutunin (HA) and neuraminidase (NA) genes are able to
cause extinction of specific clades. In contrast to human Influenza
A [50] and Norovirus GII.4 [51], no evidence of selection-driven
viral population turnover was uncovered by our posterior
predictive analysis of the whole genome (P = 0.24), which indicates
that substitutions are generally random. This, in combination with
the high degree of variability detected for the G protein allows us
to conclude that the RSV attachment process, mediated by N- and
O-linked sugars of the RSV G attachment glycoprotein, does not
put significant evolutionary constraints on the selection of
circulating variants. Consequently, the RSV G protein is not
expected to induce functional B-cell mediated immunity and is
therefore unlikely to be an effective vaccine target. For the RSV F
protein the situation is completely different given the fact that
antibodies targeting RSV F (e.g. RespiGamH, SynagisH) are clearly
protective when administered as RSV prophylactics. Our inability
to detect RSV F escape mutants indicates that immune evasion
mutations in this gene are either rare, episodic, or have a strongly
detrimental effect on virus viability. This reinforces the suitability
of RSV F as an effective vaccine target.
In conclusion, our evolutionary analysis indicates that the RSV
genome is largely conserved and, with the exception of the G
protein, almost exclusively accumulates neutral substitutions.
There is very little evidence to suggest that the evasion of adaptive
host immunity is a primary driver of the observed RSV diversity.
This might reflect a situation in which individuals with immune
systems that attempt to acquire immunologic memory of the virus
destabilize the immunologic balance of infections, both decreasing
their tolerance for RSV and, increasing the likelihood that they
will experience an enhanced disease outcome. Based on these
findings we suggest firstly that future control strategies should
target the RSV F protein and, secondly, that these strategies might
be potentiated by co-therapeutic strategies modulating natural
host immune responses.
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Figure S1 Evidence of recombination events within the
genomes of RSV isolates. (A) A/WI/629-4266/98; (B) A/WI/
629-4302/98; (C) A/WI/629-4285/98; (D) A/WI/629-3734/98;
and (E) A/WI/629-4255/98. Whereas bootscan plots indicate
regions of sequence where these isolates are differentially most
closely related to major (in green) and minor (in blue) parental
viruses, peaks in the Maxchi plots indicate the most probable
locations of recombination breakpoints. Neighbor joining trees
(Jukes Cantor model with 100 bootstrap replicates) constructed
from different regions of the RSV full genome alignment (where
region A corresponds with the genome region inherited from the
recombinant’s major parent and regions B and C correspond with
the genome regions inherited from the recombinant’s minor
parent/parents). Within these trees, recombinant sequences are
highlighted in red, sequences closely related to the recombinants’
major parents are highlighted in green, and sequences closely
related to the recombinants’ minor parents are highlighted in blue.
(ZIP)
Figure S2 Root-to-tip divergence plot. A) Distributed data
set, B) Removed data set
(TIF)
Figure S3 Phylogeny of the RSV G gene. The accession
numbers, country of isolation, isolation date and references for the
sequences included are listed in Table S3.
(TIF)
Figure S4 Bayesian Skyline plot reconstructions depict-
ing the superimposed estimated change in effective
population size through time for the distributed (blue)
and removed (red) data sets.
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Figure S5 Mutational hotspots and nucleotide sequence
variability within the RSV genome. The number of
substitutions per site (black bars) and the nucleotide sequence
variability (%) in each RSV gene calculated per strain relative to
the consensus.
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Figure S6 Pervasive and episodic selection sites in the G
gene. The G gene based phylogenetic trees show the substitution
history for episodic sites 154 and 255 plus the pervasive sites 274
and 290.
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Table S2 Primers used for cDNA preparation and whole
genome sequencing.
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Table S3 Genbank human RSV-A sequences used in this
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Table S4 Overview protein sequence variability per
RSV strain.
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